摘要
家住在福建省宁德市的陈志福老人，不久前被查出。肾癌晚期，家人已经在准备后事。没想到老人在南京军区福州总医院肿瘤科进行Dc—CIK细胞疗法后，病情出现了一定程度的好转，淋巴结、盆腔以及胸壁等处的转移灶发生了部分缓解，有效延长了该患者生存期。
同被引文献12
-
1Hirschowitz EA, Foody T, Kryscio R, et al. Autologous dendritic cell vaccines for non-small-cell lung cancer [J]. J Clin Oncol, 2004, 22 (14):2808-28t5.
-
2Sehlessinger J.Ligand-indueed,reeeptor-mediated dimerization and ac- tivation of EGF receptor [J].Cell,2002,110(6):669-672.
-
3Herbst RS,Heymach JV,Lippman SM.Lung cancer [J].N Engl J ed,2008, 359(13):1367-1380.
-
4Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard che- motherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-smallcell lung cancer(EURTAC): a mul- ticentre, opon-label, randomised phase 3 trial [ J].Lancet Oncol, 2012, 13(3): 239-246.
-
5Tiseo M, Gridelll C, Cascinu S, et al. An expanded access program of crlotinib (Tarceva) in patients with advanced non-small cell lung cancer(NSCLC):: data report from Italy [J].Lung Cancer, 2009, 64(2): 199-206.
-
6Zhou C, Wu YL, Chen G, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-posi- tive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multi- centre, open-label, randomised, phase 3 study [J]. Lancet Oncol, 2011,12(8): 735-742.
-
7Mok TS,Wu YL,Thongprasert S,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma [J].N Engl J Med, 2009,361(10): 947-957.
-
8Sun Y,Shi Y,Zhang L,et al.A randomized,double-blind phase 3 study of iconitib versus gefitinib in patients with advanced non-small cell lung cancer(NSCLC) previously treated with chemotherapy(ICOGEN) [J].J Clin Oncol,2011,29(suppl):Abstr 7522.
-
9Tan F,Shen X,Wang D,et aHcotinib (BPI-2009H),a novel EGFR tyro- sine kinase inhibitor,dlsplays potent efficacy in preclinical studies [J]. Lung Cancer,2012,76(2): 177-182.
-
10苏征,张灏,李欣,汤华.负载肺癌A549抗原的树突状细胞对细胞因子诱导的杀伤细胞特异性激活研究[J].中国慢性病预防与控制,2008,16(1):23-26. 被引量：2
-
1吴志.用“细胞导弹”袭击恶性肿瘤[J].解放军健康,2009(3):23-23.
-
2付志刚.肿瘤治疗的新模式——用“细胞导弹”摧毁癌瘤[J].开卷有益（求医问药）,2006(6):34-34.
-
3陈健,张小玉,桂永忠,孙薏,闵敏,钟国成.超声造影评价高强度聚焦超声联合细胞因子诱导的杀伤细胞治疗胰腺癌的疗效[J].临床超声医学杂志,2010,12(3):152-155. 被引量：3
-
4患癌明确后还需活检[J].大众健康,2009(5):97-97.
-
5李蕊,方艳秋,杨丹,谭岩.CIK细胞疗法对肝癌患者免疫功能的影响[J].中国老年学杂志,2013,33(3):538-539. 被引量：8
-
6高洁,何洁,夏凡,刘全阳,杜新强.自体链式CIK细胞治疗晚期肝癌临床疗效评价[J].国际肿瘤学杂志,2014,41(10):795-796.
-
7胡嫒.抗癌导弹[J].IT经理世界,2006(7):52-53.
-
8文翰.怎么制造“细胞导弹”?[J].百科知识,2006(03S):7-7.
-
9于洪涛.关于CIK细胞疗法对肝癌患者免疫功能产生的影响研究[J].中国疗养医学,2015,24(9):929-930.
-
10赵莉娟,白中红,许软成,王仲倩.介入治疗联合CIK细胞疗法治疗肝癌的临床观察[J].世界最新医学信息文摘,2013,13(17):121-122. 被引量：1
